BNR
Price
$8.29
Change
-$0.23 (-2.70%)
Updated
Aug 28 closing price
Capitalization
89.26M
TGLVY
Price
$0.62
Change
+$0.03 (+5.08%)
Updated
Aug 26 closing price
Capitalization
1.13B
Interact to see
Advertisement

BNR vs TGLVY

Header iconBNR vs TGLVY Comparison
Open Charts BNR vs TGLVYBanner chart's image
Burning Rock Biotech
Price$8.29
Change-$0.23 (-2.70%)
Volume$11.42K
Capitalization89.26M
Top Glove
Price$0.62
Change+$0.03 (+5.08%)
Volume$100
Capitalization1.13B
BNR vs TGLVY Comparison Chart in %
Loading...
BNR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TGLVY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BNR vs. TGLVY commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BNR is a Buy and TGLVY is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (BNR: $8.29 vs. TGLVY: $0.62)
Brand notoriety: BNR and TGLVY are both not notable
BNR represents the Medical Specialties, while TGLVY is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: BNR: 25% vs. TGLVY: 12%
Market capitalization -- BNR: $89.26M vs. TGLVY: $1.13B
BNR [@Medical Specialties] is valued at $89.26M. TGLVY’s [@Pharmaceuticals: Other] market capitalization is $1.13B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $169.86B to $0. The average market capitalization across the [@Medical Specialties] industry is $10.55B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BNR’s FA Score shows that 1 FA rating(s) are green whileTGLVY’s FA Score has 1 green FA rating(s).

  • BNR’s FA Score: 1 green, 4 red.
  • TGLVY’s FA Score: 1 green, 4 red.
According to our system of comparison, BNR is a better buy in the long-term than TGLVY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BNR’s TA Score shows that 4 TA indicator(s) are bullish while TGLVY’s TA Score has 4 bullish TA indicator(s).

  • BNR’s TA Score: 4 bullish, 5 bearish.
  • TGLVY’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, TGLVY is a better buy in the short-term than BNR.

Price Growth

BNR (@Medical Specialties) experienced а -15.92% price change this week, while TGLVY (@Pharmaceuticals: Other) price change was +5.18% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -0.81%. For the same industry, the average monthly price growth was +7.40%, and the average quarterly price growth was +7.26%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.60%. For the same industry, the average monthly price growth was +5.92%, and the average quarterly price growth was +15.12%.

Industries' Descriptions

@Medical Specialties (-0.81% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

@Pharmaceuticals: Other (+0.60% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TGLVY($1.13B) has a higher market cap than BNR($89.3M). BNR YTD gains are higher at: 22.815 vs. TGLVY (-45.307). TGLVY has higher annual earnings (EBITDA): 426M vs. BNR (-211.78M). TGLVY has more cash in the bank: 528M vs. BNR (495M). BNR has less debt than TGLVY: BNR (42.3M) vs TGLVY (1.01B). TGLVY has higher revenues than BNR: TGLVY (3.43B) vs BNR (523M).
BNRTGLVYBNR / TGLVY
Capitalization89.3M1.13B8%
EBITDA-211.78M426M-50%
Gain YTD22.815-45.307-50%
P/E RatioN/A82.21-
Revenue523M3.43B15%
Total Cash495M528M94%
Total Debt42.3M1.01B4%
FUNDAMENTALS RATINGS
TGLVY: Fundamental Ratings
TGLVY
OUTLOOK RATING
1..100
29
VALUATION
overvalued / fair valued / undervalued
1..100
28
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BNRTGLVY
RSI
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
87%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
71%
Bullish Trend 1 day ago
79%
MACD
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
75%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
71%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
69%
Advances
ODDS (%)
Bullish Trend 12 days ago
76%
N/A
Declines
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 18 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
82%
Bullish Trend 4 days ago
74%
Aroon
ODDS (%)
Bullish Trend 1 day ago
74%
Bearish Trend 1 day ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
BNR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TGLVY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MEMRX34.84N/A
N/A
MFS Emerging Markets Equity R1
OASGX12.24N/A
N/A
Optimum Small-Mid Cap Growth A
HWGIX16.35N/A
N/A
Hotchkis & Wiley Global Value I
NWXVX11.53N/A
N/A
Nationwide International Sm Cp Instl Svc
TRPBX25.78N/A
N/A
T. Rowe Price Spectrum Moderate Allc Inv

BNR and

Correlation & Price change

A.I.dvisor tells us that BNR and ZOMDF have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BNR and ZOMDF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BNR
1D Price
Change %
BNR100%
-2.70%
ZOMDF - BNR
28%
Poorly correlated
+0.24%
ZIMV - BNR
28%
Poorly correlated
-0.37%
RVTY - BNR
25%
Poorly correlated
+0.72%
ACRS - BNR
24%
Poorly correlated
+1.10%
STXS - BNR
24%
Poorly correlated
-2.09%
More

TGLVY and

Correlation & Price change

A.I.dvisor tells us that TGLVY and BNR have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TGLVY and BNR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TGLVY
1D Price
Change %
TGLVY100%
N/A
BNR - TGLVY
20%
Poorly correlated
-2.70%
SSMXY - TGLVY
12%
Poorly correlated
+0.16%
VPTDF - TGLVY
8%
Poorly correlated
+0.85%
TRUMY - TGLVY
3%
Poorly correlated
-0.33%
SUVPF - TGLVY
2%
Poorly correlated
N/A
More